Cargando…
Preoperative Molecular Markers in Thyroid Nodules
The need for distinguishing benign from malignant thyroid nodules has led to the pursuit of differentiating molecular markers. The most common molecular tests in clinical use are Afirma(®) Gene Expression Classifier (GEC) and Thyroseq(®) V2. Despite the rapidly developing field of molecular markers,...
Autores principales: | Sahli, Zeyad T., Smith, Philip W., Umbricht, Christopher B., Zeiger, Martha A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915469/ https://www.ncbi.nlm.nih.gov/pubmed/29720964 http://dx.doi.org/10.3389/fendo.2018.00179 |
Ejemplares similares
-
Thyroid Nodule Molecular Testing: Is It Ready for Prime Time?
por: Khan, Tahsin M., et al.
Publicado: (2020) -
Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review
por: McKelvey, Brittany A., et al.
Publicado: (2020) -
Molecular diagnostics in the evaluation of thyroid nodules: Current use and prospective opportunities
por: Patel, Jena, et al.
Publicado: (2023) -
Influence of Hashimoto thyroiditis on diagnosis and treatment of thyroid nodules
por: Mao, Linfeng, et al.
Publicado: (2022) -
Editorial: Thyroid nodules and tumors in childhood
por: de Sanctis, Luisa, et al.
Publicado: (2023)